In vivo imaging of cancer biomarkers using activatable molecular probes

Cancer Biomarkers

Volumn 4, Issue 6, 2008, Pages 287-305

  Elias, Drew R ^a   Thorek, Daniel L J ^a   Chen, Antony K ^a   Czupryna, Julie ^a   Tsourkas, Andrew ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Activatable probes; Molecular beacons; Molecular imaging; Molecular probes

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; CALPAIN; CARBOXYPEPTIDASE B; CATHEPSIN B; CELL PENETRATING PEPTIDE; DIPEPTIDYL PEPTIDASE IV; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; ESTROGEN RECEPTOR; EUROPIUM; FK 506 BINDING PROTEIN; FLUOROURACIL; GADOLINIUM; GADOLINIUM CHELATE; GELATINASE A; GELATINASE B; GLUCOSE; LACTIC ACID; MAMMALIAN TARGET OF RAPAMYCIN; MATRILYSIN; MYC PROTEIN; MYELOPEROXIDASE; MYOD PROTEIN; PROTEINASE; QUANTUM DOT; RENIN; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE; TRYPSIN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNINDEXED DRUG; YTTERBIUM;

APOPTOSIS; ARTICLE; BIOLUMINESCENCE; CANCER DIAGNOSIS; COLON CANCER; CONTRAST ENHANCEMENT; DISEASE MARKER; DRUG EFFICACY; EARLY DIAGNOSIS; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME SUBSTRATE; FLUORESCENCE ANALYSIS; FLUORESCENCE RESONANCE ENERGY TRANSFER; GENE EXPRESSION; GENOMICS; GLIOMA; HUMAN; IN VIVO STUDY; METABOLOMICS; METASTASIS POTENTIAL; MOLECULAR BEACON; MOLECULAR IMAGING; MOLECULAR PROBE; MULTIPHOTON MICROSCOPY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PANCREAS CANCER; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; PROTEIN PROTEIN INTERACTION; PROTEOMICS; SENSITIVITY AND SPECIFICITY; SIGNAL NOISE RATIO; SINGLE NUCLEOTIDE POLYMORPHISM; STOMACH CANCER;

EID: 58149385769     PISSN: 15740153     EISSN: None     Source Type: Journal    
DOI: 10.3233/CBM-2008-4602     Document Type: Article

References (113)

1. B. Vogelstein and K.W. Kinder, Cancer genes and the pathways they control, Nat Med 10 (2004), 789-799.
2. M. Kneen, J. Farinas, Y. Li and A.S. Verkman, Green fluorescent protein as a noninvasive intracellular pH indicator, Biophys J 74 (1998), 1591-1599.
3. M.A. Elsliger, R.M. Wachter, G.T. Hanson, K. Kallio and S.J. Remington, Green fluorescent protein as a noninvasive intracellular pH indicator, Biochemistry 38 (1999), 5296-5301.
4. M. Funovics, R. Weissleder and C.H. Tung, Protease sensors for bioimaging, Anal Bioanal Chem 77(6) (2003), 956-963.
5. M. Zhou and I. Ghosh, Quantum dots and peptides: A bright future together, Biopolymers 88(3) (2006), 325-339.
6. C.H. Tung, Fluorescent Peptide Probes for In Vivo Diagnostic Imaging, Biopolymers 76(5) (2004), 391-403.
7. W. McGrath, A. Pia Abola, D. Toledo, M.T. Brown and W.F. Mangel, Characterization of Human Adenovaus Proteinase Activity in Disrupted Virus Particles, Virology 217(1) (1996), 131-138.
8. H.Z. Zhang, S. Kasibhatla, J. Guastella, B. Tseng, J. Drewe and S.X. Cai, N-Ac-DEVD-N'-(Polyfluorobenzoyl)-R110: Novel cell-permeable fluorogenic caspase substrates for the detection of caspase activity and spoptosis, Bioconjug Chem 14(2) (2003), 458-463.
9. C.J.F. Van Noorden, E. Boonacker, E. Bissell, A. Meijer, J. van Marle and R. Smith, Ala-Pro-cresyl violet, a synthetic fluorogenic substrate for the analysis of kinetic parameters of dipeptidyl peptidase IV (CD26) in individual living rat hepatocytes, Anal Biochem 252(1) (1997), 71-77.
10. N.H. Ho, R. Weissleder and C.H. Tung, Development of a dual fluorogenic and chromogenic dipeptidyl peptidase IV substrate, Bioorg Med Chem Lett 16(10) (2006), 2599-2602.
11. R. Weissleder, C.H. Tung, U, Mahmood and A. Bogdanov, In vivo imaging of tumors with protease-activated NIRF probes, Nat Biotechnol 17 4) (1999), 375-378.
12. K. Shah, A. Jacobs, X.O. Breakefield and R. Weissleder, Molecular unaging of gene therapy for cancer, Gene Ther 11(15) (2004), 1175-1187.
13. U. Mahmood, C.H. Tung, A. Bogdanov and R. Weissleder, Near infrared optical imaging of protease activity for tumor detection, Radiology 213(3) (1999), 866-870.
14. C. Bremer, C.H. Tung, A. Bogdanov and R. Weissleder, Imaging of differential protease expression in breast cancers for detection of aggressive tumor phenotypes, Radiology 222(3) (2002), 814-818.
15. A. Reisenauer, O. Eickelberg, A. Wille, A. Heimburg, A. Reinhold, B.F. Sloane, T. Welte and F. Bühling, Increased carcinogenic potential of myeloid tumor cells induced by aberrant TGF-beta1-signaling and upregulation of cathepsin B, Biol Chem 388(6) (2007), 639-650.
16. B.F. Sloane, S. Yan, I. Podgorski, B.E. Linebaugh, M.L. Cher, J. Mai, D. Cavallo-Medved, M. Sameni, J. Dosescu and K. Moin, Cathepsin B and tumor proteolysis: Contribution of the tumor microenvironment, Semin Cancer Biol 15(2) (2005), 149-157.
17. I. Podgorski and B.F. Sloane, Cathepsin B and its role(s) in cancer progression, Biochem Soc Symp 70 (2003), 263-276.
18. E. Liaudet-Coopman, M. Banjouin, D. Derocq, M. Garcia, M. Glondu-Lassis, V. Laurent-Matha, C. Prébois, H. Rochefort and F. Vignon, Cathepsin D: Newly discovered functions of a long-standing aspartic protease in cancer and apoptosis, Cancer Lett 237(2) (2006), 167-179.
19. C.H. Tung, S. Bredow, U. Mahmood and R. Weissleder, Preparation of a Cathepsin D sensitive near-infrared fluorescence probe for imaging, Bioconjug Chem 10(5) (1999), 892-896.
20. C.H. Tung, U. Mahmood, S. Bredow and R. Weissleder, In vivo imaging of proteolytic enzyme activity using a novel molecular reporter, Cancer Res 60(17) (2000), 4953-4958.
21. C. Bremer, S. Bredow, U. Mahmood, R. Weissleder and C.H. Tung, Optical imaging of MMP-2 activity in tumors: Feasibility study in a mouse model, Radiology 221(2) (2001), 523-529.
22. C. Bremer, C.H. Tung and R. Weissleder, Molecular imaging of MMP Expression and therapeutic MMP Inhibition, Acad Radiol 9 Suppl 2) (2002), S314-315.
23. A. Juuti, J. Lundin, S. Nordling, J. Louhimo and C. Haglund C. Epithelial MMP-2 expression correlates with worse prognosis in pancreatic cancer, Oncology 71(1-2) (2006), 61-68. a, T. Iwata, K. Ohba, S. Kanda, M. Nishikido and H.
24. Y. Miyata, T. Iwata, K. Ohba, S. Kanda, M. Nishikido and H. Kanetake, Expression of matrix metalloproteinase-7 on cancer cells and tissue endothelial cells in renal cell carcinoma: Prognostic implications and clinical significance for invasion and metastasis, Clin Cancer Res 12(23) (2006), 6998-7003.
25. C.F. Sier, F.J. Kubben, S. Ganesh, M.M. Hoerding, G. Griffioen, R. Hanemaaijer, J.H. van Krieken, C.B. Lamers and H.W. Verspaget, Tissue levels of matrix metalloproteinases MMP-2 and MMP-9 are related to the overall survival of patients with gastric carcinoma, Br J Cancer 74(3) (1996), 413-417.
26. K. Shah, C.H. Tung, C.H. Clang, E. Slootweg, T. O'Loughlin, X. Breakefield and R. Weissleder, In Vivo Imaging of HIV Protease Activity in Amplicon Vector-transduced Gliomas, Cancer Res 64(1) (2004), 273-278.
27. A.K. Gatande, S.A. Hilderbrand, R. Weissleder and C.H. Tung, Enzyme-targeted fluorescent imaging probes on a multiple antigenic peptide core, J Med Chem 49(15) (2006), 4715-4720.
28. L. Josephson, M. Kircher, U. Mahmood and R. Weissleder, Near-Infrared Fluorescent Nanoparticles as Combined MR/Optical Imaging Probes, Bioconjug Chem 13 (2002), 554-560.
29. Y. Hama, Y. Urano, Y. Koyama, M. Kamiya, M. Bernardo, R.S. Paik, I.S. Shin, C.H. Paik, P.L. Choyke and H. Kobayashi, A Target Cell-Specific Activatable Fluorescence Probe for In vivo Molecular Imaging of Cancer Based on a Self-Quenched Avidin-Rhodamine Conjugate, Cancer Res 67(6) (2007), 2791-2799.
30. E. Matayoshi, G. Wang, G. Kafft and J. Erickson, Novel Fluorogenic Substrates for Assaying Retroviral Proteases by Resonance Energy Transfer, Science 247(4945) (1990), 954-958.
31. P. Wellington, C. Yongdoo, R. Weissleder and C.H. Tung, Developing a Peptide-Based Near-Infrared Molecular Probe for Protease Sensing, Bioconjug Chem 15 (2004), 1403-1407.
32. E. Chang, J.S. Miller, J.T. Sun, W.W. Yu, V.L. Colvin, R. Drezek and J.L. West, Protease-activated quantum dot probes, Biochem Biophys Res Commun 334 (2005), 1317-1321.
33. M.F. Kircher, L. Josephson and R. Weissleder, Ratio imaging of enzyme activity using dual wavelength optical reporters, Mol Imaging 1 2) (2002), 89-95.
34. M.F. Kircher, R. Weissleder and L. Josephson, A dual fluorochrome probe for imaging proteases, Bioconjug Chem 15(2) (2004), 242-248.
35. D. Stockholm, M. Bartoli, G. Sillon, N. Bourg, J. Davoust and I. Richard, Imaging calpain protease activity by multiphoton FRET in living mice, J Mol Biol 346(1) (20r05), 215-222.
36. N.O. Carragher and M.C. Frame, Calpain: A role in cell transformation and migration, Int J Biochem Cell Biol 34(12) (2002), 1539-1543.
37. M. Bartoli, N. Bourg, D. Stockholm, F. Raynaud, A. Delevacque, Y. Han, P. Borel, K. Seddik, N. Armande and I. Richard, A mouse Model for monitoring calpain activity under physiological and pathological conditions, J Biol Chem 281(51) (2006), 39672-39680.
38. J.O. McIntyre, B. Fingleton, K.S. Wells, D.W. Piston, C.C. Lynch, S. Gautain and L.M. Matrisian, Development of a novel fluorogenic proteolytic beacon for in vivo detection and imaging of tumour-associated matrix metalloproteinase-7 activity, Biochem J 377 (2004), 617-628.
39. I.L. Medintz, A.R. Clapp, F.M. Brunel, T. Tiefenbrunn, H.T. Uyeda, E.L. Chang, J.R. Deschamps, P.E. Dawson and H. Mattoussi, Proteolytic activity monitored by fluorescence resonance energy transfer through quantum-dot-peptide conjugates, Nat Mater 5(7) (2006), 581-589.
40. L. Shi, N. Rosenzweig and Z. Rosenzweig, Luminescent quantum dots fluorescence resonance energy transfer-based probes for enzymatic activity and enzyme inhibitors, Anal Chem 79(1) (2007), 208-214.
41. K.E. Bullok, S.T. Gammon, S. Violini, A.M. Prantner, V.M. Villalobos, V. Sharma and D. Piwnica-Worms, Permeation peptide conjugates for In Vivo Molecular Imaging Applications, Mol Imaging 5(1) (2006), 1-15.
42. J. Bullock and D. Piwnica-Worms, Synthesis and characterization of a small, membrane-permeant, caspace activatable far-red fluorescent peptide for imaging apoptosis, J Med Chem 48(17) (2005), 5404-5407.
43. K.E. Bullok, D. Maxwell, A.H. Kesarwala, S. Gammon, J.L. Prior, M. Snow, S. Stanley and D. Piwnica-Worms, Biochemical and in vivo characterization of a small, membranepermeant, caspase-activatable far-red fluorescent peptide for imaging apoptosis, Biochemistry 46(13) (2007), 4055-4065.
44. T. Jiang, E.s. Olson, Q.T. Nguyen, M. Roy, P.A. Jennings and R.Y. Tsien, Tumor imaging by means of proteolytic activation of cell-penetrating peptides, Proc Natl Acad Sci USA 101(51) (2004), 17867-17872.
45. Y. Zhang, M.K. So and J. Rao, Protease-modulated cellular uptake of quantum dots, Nano Lett 6(9) (2006), 1988-1992.
46. Y. Choi, R. Weissleder and C.H. Tung, Selective antitumor effect of novel protease-mediated photodynamic agent, Cancer Res 66 14), (2006), 7225-7229.
47. G. Zheng, J. Chen, K. Stefflova, M. Jarvi, H. Li and B.C. Wilson, Photodynamic molecular beacon as an activatable photosensitizer based on protease-controlled singlet oxygen quenching and activation, Proc Natl Acad Sci USA 104(21) (May 2007), 8989-8994.
48. K.E. Luker, M.C.P. Smith, G.D. Luker, S.T. Gammon, H. Piwnica-Worms and D. Piwnica-Worms, Kinetics of regulated protein-protein interactions revealed with firefly luciferase complementation imaging in cells and living animals, Proc Nat Acad Sci USA 101 (2004), 12288-12293.
49. R. Paulmurugan and S.S. Gambhir, Monitoring protein-protein interactions using split synthetic renilla luciferase protein-fragment-assisted complementation, Anal Chem 75 (2003), 1584-1589.
50. R. Paulmurugan and S.S. Gambhir, Combinatorial library screening for developing an improved split-firefly luciferase fragment-assisted complementation system for studying protein-protein interactions, Anal Chem 79 (2007), 2346-2353.
51. R. Paulmurugan, Y. Umezawa and S.S. Gambhir, Noninvasive imaging of protein-protein interactions in living subjects by using reporter protein complementation and reconstitution strategies, Proc Nat Acad Sci USA 99 (2002), 15608-15613.
52. R.L. Davis, H. Weintraub and A.B. Lassar, Expression of a single transfected cDNA converts fibroblasts to myoblasts, Cell 51 (1987), 987-1000.
53. R. Benezra, R.L. Davis, D. Lockshon, D.L. Turner and H. Weintraub, The protein Id: A negative regulator of helixloop-helix DNA binding proteins, Cell 61 (1990), 49-59.
54. E.J. Brown, M.W. Albers, T.B. Shin, K. Ichikawa, C.T.Keith, W.S. Lane and S.L. Schreiber, Nature 369 (1994), 756-758.
55. R. Paulmurugan, T.F. Massoud, J. Huang and S.S. Gambhir, Molecular imaging of drug-modulated protein-protein interactions in living subjects, Cancer Res 64 (2004), 2113-2119.
56. B. Laxman, D.E. Hall, M.S. Bhojani, D.A. Hamstra, T.L. Chenevert, B.D. Ross and A. Rehemtulla, Noninvasive real-time imaging of apoptosis, Proc Natl Acad Sci USA 99 (2002), 16551-16555.
57. K.C. Lee, D.A. Hamstra, M.S. Bhojani, A.P. Khan, B.D. Ross and A. Rehemtulla, Noninvasive molecular imaging sheds light on the synergy between 5-fluorouracil and TRAIL/Apo2L for cancer therapy, Clin Cancer Res 13 (2007), 1839-1846.
58. K. Shah, C.H. Tung, X.O. Breakefield and R. Weissleder, In vivo imaging of S-TRAIL-mediated tumor regression and apoptosis, Mol Ther 11 (2005), 926-931.
59. M. Plebani, L. Herszènyi, R. Cardin, G. Roveroni, P. Carraro, M.D. Paoli, M. Rugge, W.F. Grigioni, D. Nitti, R. Naccarato et al., Cysteine and serine proteases in gastric cancer, Cancer 76 (1995), 367-375.
60. K. Sheahan, S. Shuja and M.J. Murnane, Cysteine protease activities and tumor development in human colorectal carcinoma, Cancer Res 49 (1989), 3809-3814.
61. X. Tian, M.R. Auruva, W. Qin, W. Zhu, E.R. Sauter, M.L. Thakur and E.Wickstrom, Noninvasive molecular imaging of MYC mRNA expression in human breast cancer xenografts with a 99mTc peptide nucleic acid-peptide chimera, Bioconjug Chem 16 (2005), 70-79.
62. J.G. Zheng and T.Z. Tan, Antisense imaging of colon cancer-bearing nude mice with liposome-entrapped 99mtechnetium-labeled antisense oligonucleotides of c-myc mRNA, World J Gastroenterol 10 (2004), 2563-2566.
63. K. Nakamura, C. Fan, G. Liu, S. Gupta, J. He, S. Dou, A. Kubo, M. Rusckowski and D.J. Hnatowich, Evidence of antisense tumor targeting in mice, Bioconjug Chem 15 (2004), 1475-1480.
64. M.K. Dewanjee, A.K. Ghafouripour, M. Kapadvanjwala, S. Dewanjee, A.N. Serafini, D.M. Lopzes and G.N. Sfakianakis, Noninvasive imaging of c-myc oncogene messager RNA wih indium-111-antisense probes in a mammary tumor-bearing mouse model, J Nucl Med 35 (1994), 1054-1063.
65. S. Heckl, R. Pipkorn, W. Waldeck, H. Spring, J. Jenne, C. von der Lieth, H. Corban-Wlhelm, J. Debus and K. Braun, Intracellular Visualization of Prostate Cancer Using Magnetic Resonance Imaging, Cancer Research 64 (2003), 4766-4772.
66. S. Tyagi and F.R. Kramer, Molecular beacons: Probes that fluoresce upon hybridization, Nat Biotechnol 14(3), (1996), 303-308.
67. D.L. Sokol, X. Zhang, P. Lu and A.M. Gewirtz, Real time detection of DNA-RNA hybridization in living cells, Proc Natl Acad Sci USA 95 (1998), 11538-11543.
68. G. Bonnet, S. Tyagi, A. Libchaber and F.R. Kramer, Thermodynamic basis of the enhanced specificity of structured DNA probes, Proc Natl Acad Sci USA 96 (1999), 6171-6176.
69. A. Tsourkas, M.A. Behlke, S.D. Rose and G. Bao, Hybridization kinetics and thermodynamics of molecular beacons, Nucleic Acids Res 31 (2003), 1319-1330.
70. P. Mitchell, Turning the spotlight on cellular imaging, Nat Biotechnol 19 (2001), 1013-1017.
71. J.J. Li, R. Geyer and W. Tan, Using molecular beacons as a sensitive fluorescence assay for enzymatic cleavage of singlestranded DNA, Nucleic Acids Res 28 (2000), E52.
72. R.W. Dirks, C. Molenaar and H.J. Tanke, Methods for visualizing RNA processing and transport pathways in living cells, Histochem Cell biol 115 (2001), 3-11.
73. D.P. Bratu, B.J. Cha, M.M. Mhlanga, F.R. Kramer and S. Tyagi, Visualizing the distribution and transport of mRNAs in living cells, Proc Natl Acad Sci USA 100 (2003), 13308-13313.
74. S. Tyagi and O. Alsmadi, Imaging native beta-actin mRNA in motile fibroblasts, Biophys J 87(6) (2004), 4153-4162.
75. S. Tyagi and F.R. Kramer, Molecular beacons: Prob that fluoresce upon hybridization, Nat Biotech 14 (1996), 303-308.
76. R.H. Kehkenback, In vitro analysis of nuclear mRNA export using molecular beacons for target recognition, Nucleic acids res 31 (2003), e64.
77. J. Perlette and W. Tan, Real-time monitoring of intracellular mRNA hybridization inside single living cells, Anal Chem 73 (2001), 5544-5550.
78. A. Tsuji, H. Koshimoto, Y. Sato, M. Hirano, Y. Sei-Iida, S. Kondo and K. Ishibashi, Direct observation of specific messenger RNA in a single living cell under a fluorescence microscope, Biophys J 78 (2000), 3260-3274.
79. A. Tsuji, Y. Sato, M. Hirano, T. Suga, H. Koshimoto, T. Taguchi and S. Ohsuka, Development of a time-resolved fluorometric method for observing hybridization in living cells using fluorescence resonance energy transfer, Biophys J 81 (2001), 501-515.
80. A. Tsourkas, M.A. Behlke, Y. Xu and G. Bao, Spectroscopic features of dual fluorescence/luminescence resonance energy-transfer molecular beacons, Anal Chem 75 (2003), 3697-3703.
81. P.J. Santangelo, B. Nix, A. Tsourkas and G. Bao, Dual FRET molecular beacons for mRNA detection in living cells, Nucleic Acids Res 32 (2004), e57.
82. H. Abe and E.T. Kool, Flow cytometric detection of specific RNAs in native human cells with quenched autoligating FRET probes, Proc Natl Acad Sci USA 103 (2006), 263-268.
83. R. Juskaitis, T.Wilson and T.F.Watson, Real-time white light reflection confocal microscopy using a fiber-optic bundle, Scanning 19 (1997), 15-19.
84. H. Tajii, M. Kobayashi, K. Izuishi and S. Yoshida, Fluorescence endoscopy in the gastrointestinal tract, Digest Endosc 12 (2000), 28-31.
85. M.A. Funovics, H. Alencar, H.S. Su, K. Khazaie, R.Wessleder and U. Mahmood, Miniaturized multichannel near infrared endoscope for mouse imaging, Mol Imaging 2 (2003), 350-357.
86. H. Zeng, M. Petek, M.T. Zorman et al., Integrated endoscopy system for simultaneous imaging and spectroscopy for early lung cancer detection, Opt Lett 29 (2004), 587-589.
87. K.H. Al-Gubory, Fibered confocal fluorescence microscopy for imaging apoptotic DNA fragmentation at the signle-cell level in vivo, Exp Cell Res 310 (2005), 474-481.
88. A.L. Polglase, W.J. McLaren, S.A. Skinner, R. Kiesslick, M.F. Neurath and P.M. Delaney, A fluorescence confocal endomicroscope for in vivo microscopy of the upper- and the lower-GI tract, Gastrointest Endosc 62 (2005), 686-695.
89. M.T. Myaing, D.J. MacDonald and X. Li, Fiber-optic scanning two-photon fluorescence endoscope, Opt Lett 31 (2006), 1076-1078.
90. K. Marten, C. Bremer, K. Khazaie et al., Detection of dysplastic intestinal adenomas using enzyme-sensing molecular beacons in mice, Gastroenterology 122 (2002), 406-414.
91. M.A. Funovics, R. Weissleder and U. Mahmood, Catheterbased in vivo imaging of enzyme activity and gene expression: Feasibility study in mice, Radiology 231 (2004), 659-666.
92. M.A. Funovics, H. Alencar, X. Montet, R.Weissleder and U. Mahmood, Simultaneous fluorescence imaging of protease expression and vascularity during murine colonsocpy for colonic lesion characterization, Gastroint Endosc 64 (2006), 589-597.
93. H. Alencar, M.A. Funovics, J. Figueiredo, H. Sawaya, R. Weissleder and U. Mahmood, Colonic Adenocarcinomas: Near-Infrared Microcatheter Imaging of Smart Probes for Early Detection - Study in Mice, Radiology (2007), Epub.
94. L. Josephson, J.M. Perez and R. Weissleder, Magnetic nanosensors for the detection of oligonucleotide sequences, Angew Chem Int Ed Engl 40 (2001), 3204.
95. J.M. Perez, L. Josephson, T. O'Loughlin, D. Hogemann and R.Weissleder, Magnetic relaxation switches capable of sensing molecular interactions, Nat Biotechnol 20 (2002), 816-820.
96. J. Grimm, J.M. Perez, L. Josephson and R. Weissleder, Novel nanosensors for rapid analysis of telomerase activity, Cancer Res 64 (2004), 639-643.
97. J.M. Perez, F.J. Simeone, Y. Saeki, L. Josephson and R. Weissleder, Viral-induced self-assembly of magnetic nanoparticles allows the detection of viral particles in biological media, J Am Chem Soc 125 (2003), 10192-10193.
98. J.M. Perez, L. Josephson, T. O'Loughlin, D. Hogemann and R.Weissleder, Magnetic relaxation switches capable of sensing molecular interactions, Nat Biotechnol 20 (2002), 816-820.
99. J.M. Perez, T. O'Loughin, F.J. Simeone, R. Weissleder and L. Josephson, DNA-based magnetic nanoparticle assembly acts as a magnetic relaxation nanoswitch allowing screening of DNA-cleaving agents, J Am Chem Soc 124 (2002), 2856-2857.
100. M. Zhao, L. Josephson, Y. Tang and R.Weissleder, Magnetic sensors for protease assays, Angew Chem Int Ed Engl 42(12) (2003), 1375-1378.
101. S.G. Orel and M.D. Schnall, MR imaging of the breast for the detection, diagnosis, and staging of breast cancer, Radiology 220 (2001), 13-30.
102. R.A. Moats, S.E. Fraser and T.J. Meade, A Smart Magnetic Resonance Imaging Agent That Reports on Specific Enzymatic Activity, Angew Chem Int Ed Engl 36 (1997), 726-728.
103. A.Y. Louie, M.M. Hüber, E.T. Ahrens, U. Rothbächer, R. Moats, R.E. Jacobs, S.E. Fraser and T.J. Meade, In vivo visualization of gene expression using magnetic resonance imaging, Nat Biotechnol 18 (2000), 321-325.
104. R.E. Jacobs, E.T. Ahrens, T.J. Meade and S.E. Fraser, Looking deeper into vertebrate development, Trends Cell Biol 9 (1999), 73-76.
105. A.L. McMurry Nivorozhkin, A.F. Kolodziej, P. Caravan, A.T. Greengield, R.B. Lauffer and T.J. McMurry, Enzyme-Activated Gd(3+) Magnetic Resonance Imaging Contrast Agents with a Prominent Receptor-Induced Magnetization Enhancement We thank Dr. Shrikumar Nair for helpful discussions, Angew Chem Int Ed 40 (2001), 2903-2906.
106. A. Bogdanov, L. Matuszewski, C. Bremer, A. Petrovsky and R. Weissleder, Oligomerization of paramagnetic substrates result in signal amplification and can be used for MR imaging of molecular targets, Molecular Imaging 1 (2002), 16-23.
107. M. Mikawa, N. Miwa, M. Brautigan, T. Akaike and A. Maruyama, A pH-Sensitive Contrast Agent for Functional Magnetic Resonance Imaging (MRI), Chem Lett 27 (1998), 693-694.
108. M. Mikawa, N. Miwa, T. Akaike and A. Maruyama, Proceedings of the International Symposium on Controlled Release of Bioactive Materials. 26th (1999), 1158-1159.
109. R. Hovland, C. Glogrd, A.J. Aasen and J. Klaveness, Preparation and in vitro evaluation of a novel amphiphilic GdPCTA-12 derivative; a micellar MRI contrast agent, Org Biomol Chem 1(4) (2003), 644-647.
110. S. Aime, A. Barge, D. Delli Castelli, F. Fedeli, A. Mortillaro, F.U. Nielsen and E. Terreno, Paramagnetic lanthanide(III) complexes as pH-sensitive chemical exchange saturation transfer (CEST) contrast agents for MRI applications, Magn Reson Med 47 (2002), 639-648.
111. S. Zhang, K.Wu and A.D. Sherry,ANovel pH-Sensitive MRI Contrast Agent, Agnew Chem Int Ed 38 (1999), 3192-3194.
112. S. Aime, L. Anelli, M. Botta, M. Brocchetta, S. Canton, F. Fedeli, E. Gianolior and E. Terreno, Relaxometric evaluation of novel manganese(II) complexes for application as contrast agents in magnetic resonance imaging, J Biol Inorg Chem 7(1-2) (2002), 58-67.
113. S. Zhang, R. Trokowski and A.D. Shery, A paramagnetic CEST agent for imaging glucose by MRI, J Am Chem Soc 125(50) (2003), 15288-15289.